News & Events
BUCM Reveals New Anti-Fibrotic Target in Liver Study

New study in Journal of Hepatology! Prof. Li Xiaojiaoyang & Prof. Liu Runping’s teams from #BUCM reveal ETV4 as a novel anti-fibrotic target in cholestatic liver fibrosis, regulated by m6A & hyodeoxycholic acid. #LiverFibrosis#Hepatology#TCM

https://t.co/PgEf9etQxK

e372523ecdad9ead8a964f44458a55d.png